X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (458) 458
humans (419) 419
endocrinology & metabolism (247) 247
male (233) 233
female (230) 230
type 2 diabetes (225) 225
risk factors (219) 219
macrovascular disease (211) 211
middle aged (207) 207
diabetes (206) 206
mortality (159) 159
aged (158) 158
diabetes mellitus, type 2 - complications (149) 149
diabetes mellitus, type 2 - drug therapy (133) 133
macrovascular complications (126) 126
hypoglycemic agents - therapeutic use (123) 123
macrovascular events (123) 123
adult (112) 112
diabetes mellitus (106) 106
cardiovascular disease (104) 104
mellitus (101) 101
risk (96) 96
atherosclerosis (95) 95
medicine & public health (91) 91
internal medicine (87) 87
cardiovascular-disease (85) 85
complications and side effects (85) 85
myocardial-infarction (82) 82
microvascular complications (80) 80
analysis (74) 74
risk-factors (74) 74
glucose (73) 73
pioglitazone clinical-trial (72) 72
complications (71) 71
cardiac & cardiovascular systems (70) 70
glycemic control (67) 67
treatment outcome (66) 66
cardiovascular diseases (65) 65
coronary-heart-disease (65) 65
diabetes mellitus, type 2 - blood (65) 65
care and treatment (62) 62
medicine, general & internal (62) 62
macrovascular (59) 59
cardiovascular diseases - prevention & control (58) 58
insulin (58) 58
prevalence (56) 56
insulin resistance (55) 55
diabetics (54) 54
research (54) 54
hypertension (53) 53
insulin-resistance (53) 53
hypoglycemic agents - adverse effects (51) 51
pioglitazone (51) 51
diabetic angiopathies - prevention & control (50) 50
hyperglycemia (50) 50
stroke (50) 50
diabetes therapy (49) 49
follow-up (49) 49
metabolic syndrome (49) 49
metaanalysis (48) 48
blood pressure (47) 47
cardiovascular diseases - epidemiology (47) 47
cardiovascular diseases - etiology (47) 47
blood glucose - metabolism (46) 46
diabetes mellitus, type 2 - epidemiology (46) 46
disease (46) 46
health aspects (46) 46
peripheral vascular disease (46) 46
type 1 diabetes (46) 46
abridged index medicus (45) 45
diabetic angiopathies - epidemiology (45) 45
thiazolidinediones - therapeutic use (45) 45
type 2 diabetes mellitus (45) 45
glucose control (44) 44
microvascular (44) 44
cardiovascular events (43) 43
glycated hemoglobin a - metabolism (43) 43
intima-media thickness (43) 43
metabolic diseases (43) 43
prevention (43) 43
diabetes mellitus, type 1 - complications (41) 41
human physiology (40) 40
pharmacology & pharmacy (40) 40
dextrose (39) 39
association (38) 38
cohort studies (38) 38
aged, 80 and over (37) 37
animals (37) 37
clinical-trial (37) 37
health risk assessment (36) 36
outcomes (36) 36
risk assessment (36) 36
type-2 diabetes-mellitus (36) 36
coronary heart disease (35) 35
medical research (35) 35
metformin (35) 35
oxidative stress (35) 35
prospective studies (35) 35
retinopathy (35) 35
randomized controlled-trial (34) 34
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis Research and Therapy, ISSN 1478-6354, 08/2013, Volume 15, Issue 4, pp. R87 - R87
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 240, Issue 2, pp. 318 - 323
Journal Article
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 2015, Volume 109, Issue 3, pp. 485 - 492
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2016, Volume 30, Issue 7, pp. 1223 - 1228
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 07/2017, Volume 19, Issue 7, pp. 1006 - 1013
Aims: To use the Archimedes model to estimate the consequences of delays in oral antidiabetic drug (OAD) treatment intensification on glycaemic control and... 
antidiabetic drug | thiazolidinediones | macrovascular disease | sulphonylureas | DPP | 4 inhibitor | DPP-4 inhibitor | COST-EFFECTIVENESS | METAANALYSIS | HEART-FAILURE | ARCHIMEDES | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | IMPACT | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | TYPE-2 | METFORMIN MONOTHERAPY | CLINICAL-OUTCOMES | Glycated Hemoglobin A - analysis | Patient Simulation | Humans | Middle Aged | Male | Hypoglycemia - prevention & control | Diabetic Angiopathies - physiopathology | Drug Therapy, Combination - adverse effects | Hypoglycemic Agents - administration & dosage | Female | Retrospective Studies | Diabetic Angiopathies - prevention & control | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Hyperglycemia - prevention & control | Time-to-Treatment | Administration, Oral | Models, Cardiovascular | Risk Factors | Diabetes Mellitus, Type 2 - blood | Diabetic Angiopathies - epidemiology | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Hypoglycemic Agents - adverse effects | Cohort Studies | Practice Guidelines as Topic | Heart failure | Glycosylated hemoglobin | Medicine, Experimental | Medical research | Care and treatment | Hypoglycemic agents | Hypoglycemia | Patients | Index Medicus
Journal Article
Journal Article
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 11/2010, Volume 9, Issue 1, pp. 75 - 75
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1321 - 1331
Journal Article